What we need to know about long-acting ß₂-agonists: déjà vu all over again?
- PMID: 21079266
- DOI: 10.1164/rccm.201006-0941ED
What we need to know about long-acting ß₂-agonists: déjà vu all over again?
Comment on
-
Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma.Am J Respir Crit Care Med. 2010 Nov 15;182(10):1221-7. doi: 10.1164/rccm.201002-0193OC. Epub 2010 Jul 9. Am J Respir Crit Care Med. 2010. PMID: 20622031 Clinical Trial.
Similar articles
-
Assessment of the safety of long-acting β2-agonists in routine asthma care: the ASTRO-LAB protocol.NPJ Prim Care Respir Med. 2015 Jun 18;25:15040. doi: 10.1038/npjpcrm.2015.40. NPJ Prim Care Respir Med. 2015. PMID: 26086323 Free PMC article. Review. No abstract available.
-
Combination treatment in asthma: Reviewing old and new options.Pulm Pharmacol Ther. 2015 Oct;34:72-4. doi: 10.1016/j.pupt.2015.08.010. Epub 2015 Sep 10. Pulm Pharmacol Ther. 2015. PMID: 26365488 Review. No abstract available.
-
Should an inhaled corticosteroid accompany each dose of fast-acting beta2-agonist for relief of asthma symptoms?Paediatr Respir Rev. 2024 Jun;50:38-40. doi: 10.1016/j.prrv.2023.05.005. Epub 2024 Mar 29. Paediatr Respir Rev. 2024. PMID: 38565492 Review. No abstract available.
-
Mometasone/Formoterol (dulera) for asthma.Med Lett Drugs Ther. 2010 Oct 18;52(1349):83-4. Med Lett Drugs Ther. 2010. PMID: 21045758 No abstract available.
-
Lang wirksame β2-Agonisten bei Asthma – kein erhöhtes Risiko für gravierende Nebenwirkungen.Praxis (Bern 1994). 2018;107(21):1169-1170. doi: 10.1024/1661-8157/a003073. Praxis (Bern 1994). 2018. PMID: 30326817 German. No abstract available.
Cited by
-
Selecting the Optimal Therapy for Mild Asthma.Ann Am Thorac Soc. 2021 Dec;18(12):1955-1957. doi: 10.1513/AnnalsATS.202106-697ED. Ann Am Thorac Soc. 2021. PMID: 34851246 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
